Protection by flavonoids against anthracycline cardiotoxicity: from chemistry to clinical trials [PDF]
A. M. Creighton +20 more
core +1 more source
Advances in cardiac ATP-sensitive K+ channelopathies from molecules to populations. [PDF]
Terzic A +4 more
europepmc +1 more source
Resveratrol Reverses Functional Chagas Heart Disease in Mice. [PDF]
Vilar-Pereira G +12 more
europepmc +1 more source
A comparative study between catalase gene therapy and the cardioprotector monohydroxyethylrutoside (MonoHER) in protecting against doxorubicin-induced cardiotoxicity in vitro. [PDF]
Abou-El-Hassan MA +4 more
europepmc +1 more source
Potential Strategies for Overcoming Drug Resistance Pathways Using Propolis and Its Polyphenolic/Flavonoid Compounds in Combination with Chemotherapy and Radiotherapy. [PDF]
Oršolić N, Jazvinšćak Jembrek M.
europepmc +1 more source
Cathepsin B-cleavable doxorubicin prodrugs for targeted cancer therapy (Review). [PDF]
Zhong YJ, Shao LH, Li Y.
europepmc +1 more source
Early decline in left ventricular ejection fraction predicts doxorubicin cardiotoxicity in lymphoma patients. [PDF]
Nousiainen T +3 more
europepmc +1 more source
Metabolic cardioprotectors in sport: the focus on last changes in WADA Prohibited List (review)
openaire +1 more source
Eficacia y seguridad del dexrazoxane como cardioprotector en niños mexicanos con cancer
openaire +1 more source

